Metoprolol Eg

Metoprolol Tartrate, the active ingredient in Metoprolol Eg, is a beta‑adrenergic blocker presented as an oral dosage form for oral use. It lowers elevated blood pressure, relieves angina, and improves outcomes after myocardial infarction and in chronic heart failure, acting primarily in adult patients with cardiovascular disease.

GNH USA supplies Metoprolol Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Metoprolol Eg is a beta‑blocker indicated for several cardiovascular conditions.

Hypertension: reduces systolic and diastolic blood pressure, decreasing the risk of stroke and heart attack. Angina pectoris: lowers myocardial oxygen demand, relieving chest pain during exertion. Myocardial infarction: improves survival and reduces recurrent ischemic events after an acute heart attack. Heart failure: decreases mortality and hospitalisation by reducing cardiac workload and neuro‑hormonal activation. Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other tachyarrhythmias.

Metoprolol Eg may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma or COPD - Allergic reactions (rash, angioedema) - Depression or mood changes

Before prescribing Metoprolol Eg, clinicians should evaluate patient‑specific factors and monitor for potential risks.

Assess cardiovascular status: check baseline heart rate and blood pressure. Monitor for bronchospastic disease: use cautiously in asthma or chronic obstructive pulmonary disease. Adjust in renal/hepatic impairment: dose may need modification in reduced organ function. Avoid abrupt discontinuation: taper under medical supervision to prevent rebound tachycardia. Pregnancy and lactation: risk unknown; weigh benefits against potential fetal or infant exposure. Store at room temperature: keep in the original container, protect from moisture and light.

Metoprolol Eg can interact with several medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Non‑selective beta blockers (e.g., propranolol): additive bradycardia. - Calcium‑channel blockers verapamil or diltiazem: risk of severe atrioventricular block. - Clonidine: may cause rebound hypertension on abrupt withdrawal.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., thiazides): may enhance hypotensive effect. - NSAIDs: may reduce the antihypertensive efficacy of metoprolol.